Drug Shortage Report for ZITHROMAX
Report ID | 157163 |
Drug Identification Number | 02212021 |
Brand name | ZITHROMAX |
Common or Proper name | ZITHROMAX |
Company Name | PFIZER CANADA ULC |
Market Status | MARKETED |
Active Ingredient(s) | AZITHROMYCIN |
Strength(s) | 250MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | 1x6 Tablet Blister |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-07-04 |
Estimated end date | |
Actual end date | 2022-07-21 |
Shortage status | Resolved |
Updated date | 2022-07-22 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 17300 TRANS-CANADA HIGHWAY KIRKLAND, QUEBEC CANADA H9J 2M5 |
Company contact information | Customer Service / service à la clientèle : 1-888-999-8750 Email / courriel: PharmaCustomerServiceDept@pfizer.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v17 | 2022-07-22 | English | Compare |
v16 | 2022-07-21 | French | Compare |
v15 | 2022-07-21 | English | Compare |
v14 | 2022-07-05 | French | Compare |
v13 | 2022-07-05 | English | Compare |
v12 | 2022-07-02 | English | Compare |
v11 | 2022-06-01 | French | Compare |
v10 | 2022-06-01 | English | Compare |
v9 | 2022-06-01 | English | Compare |
v8 | 2022-05-05 | French | Compare |
v7 | 2022-05-05 | English | Compare |
v6 | 2022-05-04 | English | Compare |
v5 | 2022-04-14 | French | Compare |
v4 | 2022-04-14 | English | Compare |
v3 | 2022-04-12 | English | Compare |
v2 | 2022-03-23 | French | Compare |
v1 | 2022-03-23 | English | Compare |
Showing 1 to 17 of 17